| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Drug Delivery Systems | 16 | 2020 | 1365 | 2.26 | Why? |
| Curcumin | 4 | 2018 | 396 | 1.44 | Why? |
| Neovascularization, Pathologic | 2 | 2018 | 305 | 1.07 | Why? |
| Artemisia | 1 | 2021 | 27 | 0.89 | Why? |
| Drug Carriers | 7 | 2021 | 590 | 0.84 | Why? |
| Genetic Therapy | 3 | 2019 | 409 | 0.80 | Why? |
| Chitosan | 2 | 2018 | 196 | 0.73 | Why? |
| Microbiota | 2 | 2019 | 1240 | 0.73 | Why? |
| Nanoparticles | 8 | 2021 | 2040 | 0.68 | Why? |
| Liposomes | 6 | 2019 | 334 | 0.66 | Why? |
| Bevacizumab | 1 | 2018 | 149 | 0.65 | Why? |
| Respiration Disorders | 2 | 2018 | 526 | 0.55 | Why? |
| Phytotherapy | 1 | 2021 | 743 | 0.53 | Why? |
| Analgesics | 1 | 2018 | 451 | 0.52 | Why? |
| Plant Extracts | 3 | 2021 | 1514 | 0.50 | Why? |
| Insulin | 3 | 2018 | 1316 | 0.46 | Why? |
| Genital Neoplasms, Female | 1 | 2018 | 718 | 0.42 | Why? |
| Pyrimidines | 1 | 2017 | 1557 | 0.39 | Why? |
| Nanotechnology | 4 | 2020 | 821 | 0.38 | Why? |
| Sulfonamides | 1 | 2017 | 1294 | 0.37 | Why? |
| Anti-Infective Agents | 3 | 2021 | 1766 | 0.36 | Why? |
| Lung Diseases | 5 | 2021 | 2361 | 0.31 | Why? |
| Receptors, G-Protein-Coupled | 2 | 2020 | 309 | 0.30 | Why? |
| Biofilms | 2 | 2018 | 304 | 0.29 | Why? |
| Diabetes Mellitus, Type 1 | 1 | 2018 | 1969 | 0.26 | Why? |
| Antineoplastic Agents | 3 | 2019 | 3550 | 0.26 | Why? |
| Asthma | 3 | 2018 | 4383 | 0.25 | Why? |
| Nanomedicine | 2 | 2018 | 329 | 0.25 | Why? |
| Receptors, Calcium-Sensing | 1 | 2021 | 18 | 0.23 | Why? |
| Prescription Drug Misuse | 1 | 2021 | 54 | 0.21 | Why? |
| Plant Oils | 1 | 2021 | 86 | 0.21 | Why? |
| Solubility | 2 | 2018 | 382 | 0.21 | Why? |
| Essential Hypertension | 1 | 2020 | 48 | 0.21 | Why? |
| Cissus | 1 | 2019 | 3 | 0.21 | Why? |
| Islet Amyloid Polypeptide | 1 | 2019 | 7 | 0.20 | Why? |
| Diabetes Mellitus, Type 2 | 2 | 2018 | 6166 | 0.20 | Why? |
| Static Electricity | 2 | 2019 | 397 | 0.20 | Why? |
| Animals | 21 | 2021 | 78931 | 0.20 | Why? |
| Anti-Inflammatory Agents | 2 | 2018 | 6153 | 0.20 | Why? |
| Theranostic Nanomedicine | 1 | 2020 | 143 | 0.20 | Why? |
| Receptors, Purinergic P1 | 1 | 2019 | 17 | 0.20 | Why? |
| Tripterygium | 1 | 2018 | 15 | 0.20 | Why? |
| Medicine, Traditional | 1 | 2021 | 189 | 0.19 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2021 | 8843 | 0.19 | Why? |
| Adenylate Kinase | 1 | 2018 | 13 | 0.19 | Why? |
| Tristetraprolin | 1 | 2018 | 4 | 0.19 | Why? |
| Lung Diseases, Obstructive | 1 | 2018 | 46 | 0.19 | Why? |
| Bifidobacterium | 1 | 2018 | 52 | 0.18 | Why? |
| Delayed-Action Preparations | 2 | 2018 | 291 | 0.18 | Why? |
| Drug Liberation | 1 | 2018 | 141 | 0.18 | Why? |
| MicroRNAs | 4 | 2018 | 1787 | 0.18 | Why? |
| Plant Preparations | 2 | 2020 | 276 | 0.18 | Why? |
| Drug Compounding | 2 | 2018 | 386 | 0.18 | Why? |
| Genes, Tumor Suppressor | 1 | 2017 | 43 | 0.18 | Why? |
| Glucagon-Like Peptide 1 | 1 | 2018 | 83 | 0.18 | Why? |
| PPAR gamma | 1 | 2018 | 102 | 0.17 | Why? |
| Cell Death | 1 | 2020 | 536 | 0.17 | Why? |
| Indazoles | 1 | 2017 | 77 | 0.17 | Why? |
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2017 | 15 | 0.17 | Why? |
| Metal Nanoparticles | 3 | 2019 | 771 | 0.17 | Why? |
| Spectroscopy, Fourier Transform Infrared | 1 | 2018 | 207 | 0.17 | Why? |
| Sirtuin 1 | 1 | 2018 | 100 | 0.17 | Why? |
| Morus | 1 | 2017 | 41 | 0.16 | Why? |
| Interdisciplinary Studies | 1 | 2017 | 95 | 0.16 | Why? |
| Plants, Medicinal | 2 | 2020 | 622 | 0.16 | Why? |
| Fatty Acids | 1 | 2018 | 238 | 0.16 | Why? |
| Hydrogels | 1 | 2018 | 173 | 0.16 | Why? |
| Drug Discovery | 3 | 2020 | 3092 | 0.16 | Why? |
| Tissue Scaffolds | 1 | 2018 | 174 | 0.16 | Why? |
| Polymers | 1 | 2021 | 507 | 0.16 | Why? |
| Genetic Engineering | 1 | 2018 | 325 | 0.16 | Why? |
| Tissue Engineering | 1 | 2018 | 190 | 0.16 | Why? |
| Triterpenes | 1 | 2018 | 199 | 0.16 | Why? |
| Diabetes Complications | 2 | 2019 | 2358 | 0.15 | Why? |
| Copper | 1 | 2019 | 288 | 0.15 | Why? |
| Analgesics, Non-Narcotic | 1 | 2017 | 164 | 0.15 | Why? |
| Glioblastoma | 1 | 2018 | 187 | 0.15 | Why? |
| Bacteriophages | 1 | 2018 | 268 | 0.15 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 372 | 0.15 | Why? |
| Humans | 50 | 2021 | 930598 | 0.14 | Why? |
| Serine Proteinase Inhibitors | 1 | 2019 | 341 | 0.14 | Why? |
| Exosomes | 1 | 2021 | 567 | 0.14 | Why? |
| Angiotensin II Type 1 Receptor Blockers | 1 | 2020 | 520 | 0.14 | Why? |
| Immunotherapy | 2 | 2018 | 2421 | 0.14 | Why? |
| Adenosine | 1 | 2019 | 509 | 0.14 | Why? |
| Neoplasms | 3 | 2018 | 17251 | 0.14 | Why? |
| RNA | 2 | 2021 | 1278 | 0.13 | Why? |
| Students, Health Occupations | 1 | 2017 | 224 | 0.13 | Why? |
| Acetaminophen | 1 | 2017 | 326 | 0.13 | Why? |
| Protective Agents | 1 | 2017 | 250 | 0.13 | Why? |
| NF-kappa B | 1 | 2021 | 1301 | 0.13 | Why? |
| Pulmonary Disease, Chronic Obstructive | 4 | 2019 | 3832 | 0.13 | Why? |
| Angiogenesis Inhibitors | 1 | 2017 | 395 | 0.13 | Why? |
| Anti-Bacterial Agents | 3 | 2021 | 10083 | 0.13 | Why? |
| Central Nervous System Diseases | 1 | 2019 | 410 | 0.13 | Why? |
| Particle Size | 1 | 2018 | 1052 | 0.13 | Why? |
| Tuberculosis, Multidrug-Resistant | 1 | 2018 | 433 | 0.12 | Why? |
| Hydrogen-Ion Concentration | 1 | 2017 | 993 | 0.12 | Why? |
| Molecular Targeted Therapy | 2 | 2021 | 1579 | 0.12 | Why? |
| Neurodegenerative Diseases | 1 | 2019 | 469 | 0.12 | Why? |
| Camelus | 1 | 2021 | 1425 | 0.12 | Why? |
| Dermatologic Agents | 1 | 2018 | 489 | 0.12 | Why? |
| Printing, Three-Dimensional | 1 | 2018 | 624 | 0.11 | Why? |
| Mucormycosis | 1 | 2021 | 832 | 0.11 | Why? |
| Antitubercular Agents | 1 | 2018 | 775 | 0.11 | Why? |
| Dengue Virus | 1 | 2019 | 910 | 0.11 | Why? |
| Administration, Inhalation | 1 | 2018 | 1647 | 0.11 | Why? |
| Brain Neoplasms | 1 | 2018 | 669 | 0.11 | Why? |
| Lung Neoplasms | 2 | 2019 | 3228 | 0.11 | Why? |
| Lung | 2 | 2019 | 31049 | 0.11 | Why? |
| Plasma | 1 | 2021 | 1809 | 0.11 | Why? |
| Steroids | 1 | 2017 | 904 | 0.11 | Why? |
| Oxidative Stress | 2 | 2018 | 2050 | 0.11 | Why? |
| Metformin | 1 | 2018 | 640 | 0.11 | Why? |
| Respiratory Tract Diseases | 1 | 2019 | 1061 | 0.10 | Why? |
| Clinical Trials as Topic | 3 | 2018 | 7330 | 0.10 | Why? |
| Saudi Arabia | 1 | 2021 | 4423 | 0.10 | Why? |
| Mice | 6 | 2018 | 21357 | 0.10 | Why? |
| Biological Products | 3 | 2019 | 2331 | 0.10 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.10 | Why? |
| Antioxidants | 1 | 2019 | 1593 | 0.10 | Why? |
| Mycobacterium tuberculosis | 1 | 2018 | 1164 | 0.09 | Why? |
| Viral Vaccines | 2 | 2021 | 7560 | 0.09 | Why? |
| Drug Design | 2 | 2018 | 2627 | 0.09 | Why? |
| CRISPR-Cas Systems | 1 | 2018 | 1397 | 0.09 | Why? |
| Learning | 1 | 2017 | 1181 | 0.09 | Why? |
| Dendrimers | 2 | 2019 | 104 | 0.09 | Why? |
| Antiviral Agents | 5 | 2021 | 41703 | 0.09 | Why? |
| Pulmonary Fibrosis | 1 | 2018 | 1068 | 0.09 | Why? |
| Lipids | 3 | 2018 | 1079 | 0.08 | Why? |
| Signal Transduction | 3 | 2019 | 7207 | 0.08 | Why? |
| Macrophages | 1 | 2019 | 2784 | 0.08 | Why? |
| Inflammation | 5 | 2021 | 13255 | 0.08 | Why? |
| Vaccination | 3 | 2021 | 19050 | 0.08 | Why? |
| Chiroptera | 1 | 2021 | 3530 | 0.08 | Why? |
| Skin | 1 | 2018 | 2096 | 0.08 | Why? |
| Coronavirus Infections | 9 | 2021 | 253789 | 0.07 | Why? |
| Dementia | 1 | 2019 | 1861 | 0.07 | Why? |
| Renin-Angiotensin System | 1 | 2020 | 3661 | 0.07 | Why? |
| Chronic Disease | 1 | 2019 | 5139 | 0.07 | Why? |
| Psoriasis | 1 | 2018 | 1739 | 0.07 | Why? |
| Models, Molecular | 1 | 2018 | 7616 | 0.07 | Why? |
| Gold | 2 | 2018 | 592 | 0.07 | Why? |
| RNA, Small Interfering | 2 | 2018 | 817 | 0.06 | Why? |
| Computer Simulation | 1 | 2018 | 4982 | 0.06 | Why? |
| Gastrointestinal Diseases | 1 | 2018 | 2580 | 0.06 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.06 | Why? |
| Cell Line | 1 | 2018 | 12040 | 0.06 | Why? |
| Kidney | 1 | 2017 | 3648 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.06 | Why? |
| Nervous System Diseases | 1 | 2021 | 4092 | 0.06 | Why? |
| Viral Nonstructural Proteins | 1 | 2019 | 4810 | 0.05 | Why? |
| Vitamin B 6 | 1 | 2020 | 18 | 0.05 | Why? |
| Synapses | 1 | 2021 | 83 | 0.05 | Why? |
| Models, Biological | 1 | 2018 | 4907 | 0.05 | Why? |
| Respiratory Tract Infections | 1 | 2021 | 6817 | 0.05 | Why? |
| Green Chemistry Technology | 1 | 2019 | 40 | 0.05 | Why? |
| Autoimmune Diseases of the Nervous System | 1 | 2021 | 141 | 0.05 | Why? |
| Pentacyclic Triterpenes | 1 | 2018 | 45 | 0.05 | Why? |
| Vitamin B 12 | 1 | 2020 | 132 | 0.05 | Why? |
| Emulsions | 1 | 2018 | 80 | 0.05 | Why? |
| Antigens | 1 | 2021 | 267 | 0.05 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| Folic Acid | 1 | 2020 | 172 | 0.05 | Why? |
| Blotting, Northern | 1 | 2018 | 51 | 0.05 | Why? |
| Deoxycholic Acid | 1 | 2018 | 17 | 0.05 | Why? |
| Thiazolidinediones | 1 | 2018 | 70 | 0.05 | Why? |
| Attitude of Health Personnel | 1 | 2017 | 4741 | 0.05 | Why? |
| Nervous System | 1 | 2021 | 303 | 0.05 | Why? |
| Anticarcinogenic Agents | 1 | 2018 | 25 | 0.05 | Why? |
| Ursodeoxycholic Acid | 1 | 2018 | 25 | 0.05 | Why? |
| Medication Adherence | 2 | 2018 | 1270 | 0.05 | Why? |
| Bacterial Adhesion | 1 | 2018 | 69 | 0.04 | Why? |
| Cystic Fibrosis | 2 | 2018 | 1104 | 0.04 | Why? |
| Biomarkers | 2 | 2019 | 23361 | 0.04 | Why? |
| Porosity | 1 | 2018 | 185 | 0.04 | Why? |
| Islets of Langerhans | 1 | 2019 | 138 | 0.04 | Why? |
| Gram-Positive Bacteria | 1 | 2019 | 230 | 0.04 | Why? |
| Nanocapsules | 1 | 2018 | 54 | 0.04 | Why? |
| Administration, Cutaneous | 1 | 2018 | 229 | 0.04 | Why? |
| Plant Bark | 1 | 2017 | 39 | 0.04 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.04 | Why? |
| Protein Isoforms | 1 | 2018 | 347 | 0.04 | Why? |
| Apoptosis | 2 | 2018 | 2335 | 0.04 | Why? |
| Microspheres | 1 | 2018 | 261 | 0.04 | Why? |
| RNA Processing, Post-Transcriptional | 1 | 2018 | 110 | 0.04 | Why? |
| In Situ Hybridization, Fluorescence | 1 | 2018 | 207 | 0.04 | Why? |
| Gene Silencing | 1 | 2017 | 213 | 0.04 | Why? |
| Titanium | 1 | 2018 | 175 | 0.04 | Why? |
| Cell Cycle | 1 | 2018 | 329 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2019 | 8207 | 0.04 | Why? |
| Blood-Brain Barrier | 1 | 2021 | 531 | 0.04 | Why? |
| RNA, Untranslated | 1 | 2017 | 140 | 0.04 | Why? |
| 3' Untranslated Regions | 1 | 2017 | 318 | 0.04 | Why? |
| Organ Specificity | 1 | 2021 | 1070 | 0.04 | Why? |
| RNA Stability | 1 | 2018 | 285 | 0.04 | Why? |
| Calcium | 1 | 2021 | 708 | 0.04 | Why? |
| Gene Editing | 1 | 2019 | 330 | 0.04 | Why? |
| Neoplasm Invasiveness | 1 | 2017 | 582 | 0.04 | Why? |
| DNA | 1 | 2021 | 778 | 0.04 | Why? |
| Gene Expression Regulation | 2 | 2018 | 4020 | 0.04 | Why? |
| Rats, Wistar | 1 | 2017 | 621 | 0.04 | Why? |
| Antibodies | 1 | 2021 | 846 | 0.03 | Why? |
| Gram-Negative Bacteria | 1 | 2019 | 473 | 0.03 | Why? |
| Neoplasm Metastasis | 1 | 2017 | 682 | 0.03 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.03 | Why? |
| Th2 Cells | 1 | 2018 | 680 | 0.03 | Why? |
| Glucose | 1 | 2018 | 573 | 0.03 | Why? |
| Orthomyxoviridae Infections | 1 | 2021 | 1001 | 0.03 | Why? |
| Cell Movement | 1 | 2017 | 695 | 0.03 | Why? |
| Protein Biosynthesis | 1 | 2018 | 653 | 0.03 | Why? |
| Ligands | 1 | 2018 | 1300 | 0.03 | Why? |
| Immunity, Herd | 1 | 2021 | 1011 | 0.03 | Why? |
| Central Nervous System | 1 | 2019 | 701 | 0.03 | Why? |
| Metabolic Diseases | 1 | 2018 | 505 | 0.03 | Why? |
| RNA, Long Noncoding | 1 | 2018 | 408 | 0.03 | Why? |
| Pseudomonas aeruginosa | 1 | 2018 | 652 | 0.03 | Why? |
| Transcription Factors | 1 | 2018 | 784 | 0.03 | Why? |
| Polysaccharides | 1 | 2020 | 854 | 0.03 | Why? |
| Viral Tropism | 1 | 2021 | 1329 | 0.03 | Why? |
| Cerebrovascular Disorders | 1 | 2021 | 1040 | 0.03 | Why? |
| Mice, Knockout | 1 | 2017 | 1815 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2018 | 1136 | 0.03 | Why? |
| Malaysia | 1 | 2017 | 1116 | 0.03 | Why? |
| Th1 Cells | 1 | 2018 | 1228 | 0.03 | Why? |
| Intensive Care Units | 1 | 2018 | 29594 | 0.03 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2021 | 1234 | 0.03 | Why? |
| Transcription, Genetic | 1 | 2017 | 1326 | 0.03 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 1014 | 0.03 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 711 | 0.03 | Why? |
| Staphylococcus aureus | 1 | 2018 | 844 | 0.03 | Why? |
| United States Food and Drug Administration | 1 | 2018 | 1276 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2019 | 3608 | 0.03 | Why? |
| Precision Medicine | 1 | 2020 | 1477 | 0.03 | Why? |
| Microbial Sensitivity Tests | 1 | 2019 | 2886 | 0.03 | Why? |
| Drug Industry | 1 | 2018 | 689 | 0.03 | Why? |
| Escherichia coli | 1 | 2018 | 1547 | 0.03 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.03 | Why? |
| Immunity | 1 | 2021 | 2651 | 0.02 | Why? |
| Adaptive Immunity | 1 | 2021 | 2585 | 0.02 | Why? |
| Rats | 1 | 2017 | 2764 | 0.02 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.02 | Why? |
| Drug Resistance, Bacterial | 1 | 2018 | 1414 | 0.02 | Why? |
| Drug Approval | 1 | 2018 | 1325 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2018 | 5814 | 0.02 | Why? |
| Bacteria | 1 | 2018 | 1897 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.02 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2020 | 3607 | 0.02 | Why? |
| Communicable Diseases, Emerging | 1 | 2021 | 2523 | 0.02 | Why? |
| Prognosis | 2 | 2021 | 32490 | 0.02 | Why? |
| Hypoxia | 1 | 2021 | 3626 | 0.02 | Why? |
| Glucocorticoids | 1 | 2021 | 4431 | 0.02 | Why? |
| Perception | 1 | 2017 | 2827 | 0.02 | Why? |
| Arthritis, Rheumatoid | 1 | 2018 | 2043 | 0.02 | Why? |
| Hypoglycemic Agents | 1 | 2018 | 2165 | 0.02 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.02 | Why? |
| Emergency Medical Services | 1 | 2021 | 3557 | 0.02 | Why? |
| HEK293 Cells | 1 | 2018 | 8394 | 0.02 | Why? |
| Receptors, Virus | 1 | 2021 | 5659 | 0.02 | Why? |
| India | 1 | 2021 | 11875 | 0.02 | Why? |
| RNA, Messenger | 1 | 2018 | 5131 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2018 | 6740 | 0.02 | Why? |
| Computational Biology | 1 | 2018 | 4514 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.01 | Why? |
| Models, Theoretical | 1 | 2020 | 6659 | 0.01 | Why? |
| Virus Internalization | 1 | 2020 | 7921 | 0.01 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.01 | Why? |
| Female | 2 | 2020 | 380317 | 0.01 | Why? |
| Child | 2 | 2021 | 70012 | 0.01 | Why? |
| Virus Replication | 1 | 2019 | 14331 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2021 | 12361 | 0.01 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| United States | 1 | 2018 | 46150 | 0.01 | Why? |
| Adolescent | 1 | 2021 | 86841 | 0.01 | Why? |
| Young Adult | 1 | 2021 | 93724 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.01 | Why? |
| Adult | 1 | 2021 | 244371 | 0.00 | Why? |
| Male | 1 | 2020 | 367725 | 0.00 | Why? |